Opgenra

Opgenra Uses, Dosage, Side Effects, Food Interaction and all others data.

A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Opgenra is an ingredient in the EMA-withdrawn product Osigraft.

Trade Name Opgenra
Generic Eptotermin alfa
Eptotermin alfa Other Names BMP-7, Bone morphogenetic protein 7, Eptotermin alfa, Eptotermina alfa, HBMP7, HrBMP-7, Human recombinant bone morphogenetic protein 7, OP-1, Osteogenic protein 1, RH-polypeptide-52
Type
Groups Approved, Investigational, Withdrawn
Therapeutic Class
Manufacturer Howmedica International S De R L, Olympus
Available Country France, Netherlands, Portugal, Spain
Last Updated: September 19, 2023 at 7:00 am
Opgenra
Opgenra

Innovators Monograph

You find simplified version here Opgenra

*** Taking medicines without doctor's advice can cause long-term problems.
Share